Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

20%

1 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

Phase 3
1(50.0%)
Phase 2
1(50.0%)
2Total
Phase 3(1)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT04833426Phase 3Recruiting

Impact of Peri-operative tEstosterone Levels on oNcological and Functional Outcomes in RadiCal prostatEctomy

Role: collaborator

NCT04492553Phase 2Completed

Gonadal Dysfunction in Male Long-term Survivors of Malignant Lymphoma; Vitality

Role: collaborator

NCT03437109Completed

Efficacy of Androgen Substitution for Hypogonadism in Men With Type 2 Diabetes Mellitus

Role: lead

NCT03309735Completed

Non-interventional Study of Therapy for Threatened Miscarriage

Role: lead

NCT00858650Completed

Registry of Hypogonadism in Men

Role: collaborator

All 5 trials loaded